R. K. Webber

发表

Inhibitors of human nitric oxide synthase isoforms with the carbamidine moiety as a common structural element.

M. Currie, W. M. Moore, G. Jerome, 1996, Bioorganic & medicinal chemistry.

The antagonists but not partial agonists of glucocorticoid receptor ligands show substantial side effect dissociation.

X. Hu, E. Webb, M. Obukowicz, 2011, Endocrinology.

2-Iminopiperidine and other 2-iminoazaheterocycles as potent inhibitors of human nitric oxide synthase isoforms.

M. Currie, T. P. Misko, W. M. Moore, 1996, Journal of medicinal chemistry.

2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS).

M. Currie, T. P. Misko, W. M. Moore, 1998, Journal of medicinal chemistry.

Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms.

M. Currie, M. Toth, W. M. Moore, 1998, Journal of medicinal chemistry.

Selective heterocyclic amidine inhibitors of human inducible nitric oxide synthase.

M. Toth, W. M. Moore, S. Metz, 2001, Bioorganic & medicinal chemistry letters.

L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase.

M. Currie, T. P. Misko, W. M. Moore, 1994, Journal of medicinal chemistry.

Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase.

M. Currie, W. M. Moore, G. Jerome, 1995, European journal of pharmacology.

Specific inhibitors of inducible nitric oxide synthase: Efficacy in a rodent model of sepsis

M. Currie, G. Jerome, D. Widomski, 1999, Inflammation Research.